NEW YORK, Sept. 2, 2015 /PRNewswire/ -- Seeger Weiss LLP is reporting that Zimmer Holdings Inc.'s NexGen knee implant bellwether trial will commence October 13, 2015.
Since the product was approved in 1995 using the 510K fast-track approval program, Zimmer NexGen knee implant surpassed FDA investigation and mandatory product testing. The program only requires that companies provide evidence that the product is substantially similar to a preexisting and approved product in order to gain permissions.
In 2001, Zimmer began distributing High Flex NexGen knee implants which were an updated version of the NexGen implants. The new Zimmer knee devices were supposed to provide patients with a wider range of motion, but many claims have been made that defective High Flex knee implants caused increased pain, loosening of the device, premature knee implant failure, and expensive revision surgery.
Currently, over one thousand cases have been consolidated in a multidistrict litigation in the Northern District of Illinois. The upcoming bellwether trials are intended to give plaintiffs and their attorneys in the remaining number of cases a better idea as to how juries will respond to certain evidence and testimonies that will be recurring throughout all similar trials.
Seeger Weiss LLP is currently investigating Zimmer Holdings, Inc. knee implants. If you believe you have been injured due to defective knee implants or wish to learn more, go to our NexGen Lawsuit page.
Seeger Weiss LLP is one of the nation's leading trial law firms handling complex individual, mass and class action litigation on behalf of consumers, investors, injured persons and whistleblowers. The firm, with offices in New York, Philadelphia and New Jersey, represents plaintiffs throughout litigation and as trial counsel in a variety of practice areas, including financial, securities and investment fraud, pharmaceutical injury, consumer protection, qui tam (whistleblower cases), environmental and asbestos exposures, personal injury and medical malpractice, product defect, antitrust, and commercial disputes. For more information, go to www.seegerweiss.com.
http://ryortho.com/breaking/zimmer-and-nexgen-go-on-trial-in-october/
http://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-August-17-2015.pdf
Contact:
Christopher A. Seeger, (212) 584-0700 or [email protected]
Jeffrey S. Grand (212) 584-0700 or [email protected]
Logo - http://photos.prnewswire.com/prnh/20150527/218876LOGO
SOURCE Seeger Weiss LLP
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article